- Home
- KLXE vs PYPD Comparison
KLXE vs PYPD Comparison
Compare KLXE & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KLXE
- PYPD
- Stock Information
- Founded
- KLXE 2018
- PYPD 2008
- Country
- KLXE United States
- PYPD Israel
- Employees
- KLXE N/A
- PYPD N/A
- Industry
- KLXE Oilfield Services/Equipment
- PYPD Medical/Dental Instruments
- Sector
- KLXE Energy
- PYPD Health Care
- Exchange
- KLXE Nasdaq
- PYPD Nasdaq
- Market Cap
- KLXE 35.8M
- PYPD 34.8M
- IPO Year
- KLXE N/A
- PYPD 2020
- Fundamental
- Price
- KLXE $1.96
- PYPD $3.35
- Analyst Decision
- KLXE
- PYPD Strong Buy
- Analyst Count
- KLXE 0
- PYPD 5
- Target Price
- KLXE N/A
- PYPD $12.00
- AVG Volume (30 Days)
- KLXE 113.3K
- PYPD 71.2K
- Earning Date
- KLXE 10-30-2025
- PYPD 08-13-2025
- Dividend Yield
- KLXE N/A
- PYPD N/A
- EPS Growth
- KLXE N/A
- PYPD N/A
- EPS
- KLXE N/A
- PYPD N/A
- Revenue
- KLXE $667,400,000.00
- PYPD N/A
- Revenue This Year
- KLXE N/A
- PYPD N/A
- Revenue Next Year
- KLXE $3.97
- PYPD N/A
- P/E Ratio
- KLXE N/A
- PYPD N/A
- Revenue Growth
- KLXE N/A
- PYPD N/A
- 52 Week Low
- KLXE $1.46
- PYPD $2.30
- 52 Week High
- KLXE $7.66
- PYPD $3.93
- Technical
- Relative Strength Index (RSI)
- KLXE 56.54
- PYPD 42.93
- Support Level
- KLXE $1.87
- PYPD $3.42
- Resistance Level
- KLXE $2.05
- PYPD $3.56
- Average True Range (ATR)
- KLXE 0.14
- PYPD 0.15
- MACD
- KLXE 0.03
- PYPD -0.01
- Stochastic Oscillator
- KLXE 74.29
- PYPD 33.33
About KLXE KLX Energy Services Holdings Inc.
KLX Energy Services Holdings Inc is a provider of completion, intervention and production services and products to the onshore oil and gas producing regions of the United States. It serves the companies engaged in the exploration and development of onshore conventional and unconventional oil and natural gas reserves. Its products and services offerings include surface facilities and equipment, pressure control services, wireline services, fishing services, and engineered products. The company's segments include Southwest; Rocky Mountains and Northeast/Mid-Con region. It derives maximum revenue from Northeast/Mid-Con region.
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.